These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 78960)

  • 1. Arrest and metastasis of blood-borne tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells.
    Poste G; Nicolson GL
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):399-403. PubMed ID: 6928631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement-dependent antiviral monospecific antibody-mediated lysis of murine cells coated with Sendai virus or its envelope component.
    Hosaka Y; Fukami Y; Yasuda Y; Bonilla JA
    Infect Immun; 1980 Feb; 27(2):355-63. PubMed ID: 6247274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro secondary generation of cytotoxic T lymphocytes in mice with mumps virus and their mumps-specific cytotoxicity among paramyxoviruses.
    Hosaka Y; Yasuda Y; Seriburi O; Moran MG; Fukai K
    J Virol; 1986 Mar; 57(3):1113-8. PubMed ID: 3081733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninfectious rotavirus (strain RRV) induces an immune response in mice which protects against rotavirus challenge.
    Offit PA; Dudzik KI
    J Clin Microbiol; 1989 May; 27(5):885-8. PubMed ID: 2545743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of envelope proteins of paramyxoviruses in the modification of cell membrane antigens.
    Eaton MD
    Arch Virol; 1979; 61(4):327-36. PubMed ID: 229798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro induction of T-lymphocyte-mediated cytotoxicity by infectious murine type C oncornaviruses.
    Taniyama T; Holden HT
    J Exp Med; 1979 Dec; 150(6):1367-82. PubMed ID: 229187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell membrane antigens recognized by anti-viral and anti-trinitrophenyl cytotoxic T lymphocytes.
    Ciavarra R; Forman J
    Immunol Rev; 1981; 58():73-94. PubMed ID: 6273294
    [No Abstract]   [Full Text] [Related]  

  • 8. Involvement of fusion activity of ultraviolet light-inactivated Sendai virus in formation of target antigens recognized by cytotoxic T cells.
    Sugamura K; Shimizu K; Bach FH
    J Exp Med; 1978 Jul; 148(1):276-87. PubMed ID: 78960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint recognition by cytotoxic T cells of inactivated Sendai virus and products of the major histocompatibility complex.
    Schrader JW; Edelman GM
    J Exp Med; 1977 Mar; 145(3):523-39. PubMed ID: 233918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-liposome modification of target cells as a method to alter their susceptibility to lysis by cytotoxic T lymphocytes.
    Hale AH; Ruebush MJ; Lyles DS; Harris DT
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6105-8. PubMed ID: 6255476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elicitation of anti-Sendai virus cytotoxic T lymphocytes by viral and H-2 antigens incorporated into the same lipid bilayer by membrane fusion and by reconstitution into liposomes.
    Hale AH; Lyles DS; Fan DP
    J Immunol; 1980 Feb; 124(2):724-31. PubMed ID: 6243330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference in capacity of Sendai virus envelope components to induce cytotoxic T lymphocytes in primary and secondary immune responses.
    Fukami Y; Hosaka Y; Yasuda Y; Bonilla JA
    Infect Immun; 1979 Dec; 26(3):815-21. PubMed ID: 231009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elicitation of anti-viral cytotoxic T lymphocytes with purified viral and H-2 antigens.
    Hale AH; Ruebush MJ; Harris DT
    J Immunol; 1980 Jul; 125(1):428-30. PubMed ID: 6247399
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.